Luca Gattinoni

Scopus Author ID ResearcherID Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 22

Top Venues

Nature immunology

Nature communications

Nature nanotechnology

Signal transduction and targeted therapy

Regensburg Center for Interventional Immunology

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Regensburg Center for Interventional Immunology Oct 01 2019

Germany

Chair/Professor :: Functional Immune Cell Modualtion

National Cancer Institute Mar 24 2013 - Sep 30 2019

United States

Investigator :: Experimental Transplantation and Immunology Branch

National Cancer Institute

United States

Staff Scientist :: Surgery Branch

National Cancer Institute

United States

Postdoctoral Fellow :: Surgery BRanch

Publications

Dragana Slavkovic-Lukic, Luca Gattinoni
Nanowires engineer naive T cells for immunotherapy. Nature nanotechnology 19 (8) (2024)
Dragana Slavkovic-Lukic, Luca Gattinoni
Nanowires engineer naive T cells for immunotherapy. Nature nanotechnology (2024)
Roland C Schelker, Jessica Fioravanti, Fabio Mastrogiovanni, Jeremy G Baldwin, Nisha Rana, Peng Li, Ping Chen, Timea Vadász, Rosanne Spolski, Christoph Heuser, Dragana Slavkovic-Lukic, Pedro Noronha, Giuseppe Damiano, Laura Raccosta, Daniela Maggioni, Sree Pullugula, Jian-Xin Lin, Jangsuk Oh, Patrick Grandinetti, Mario Lecce, Leo Hesse, Emilia Kocks, Azucena Martín-Santos, Claudia Gebhard, William G Telford, Yun Ji, Nicholas P Restifo, Vincenzo Russo, Michael Rehli, Wolfgang Herr, Warren J Leonard, Luca Gattinoni
LIM-domain-only 4 (LMO4) enhances CD8 + T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling. Signal transduction and targeted therapy 9 (1) (2024)
Roland C Schelker, Jessica Fioravanti, Fabio Mastrogiovanni, Jeremy G Baldwin, Nisha Rana, Peng Li, Ping Chen, Timea Vadász, Rosanne Spolski, Christoph Heuser, Dragana Slavkovic-Lukic, Pedro Noronha, Giuseppe Damiano, Laura Raccosta, Daniela Maggioni, Sree Pullugula, Jian-Xin Lin, Jangsuk Oh, Patrick Grandinetti, Mario Lecce, Leo Hesse, Emilia Kocks, Azucena Martín-Santos, Claudia Gebhard, William G Telford, Yun Ji, Nicholas P Restifo, Vincenzo Russo, Michael Rehli, Wolfgang Herr, Warren J Leonard, Luca Gattinoni
LIM-domain-only 4 (LMO4) enhances CD8 + T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling. Signal transduction and targeted therapy 9 (1) (2024)
Roland C Schelker, Jessica Fioravanti, Fabio Mastrogiovanni, Jeremy G Baldwin, Nisha Rana, Peng Li, Ping Chen, Timea Vadász, Rosanne Spolski, Christoph Heuser, Dragana Slavkovic-Lukic, Pedro Noronha, Giuseppe Damiano, Laura Raccosta, Daniela Maggioni, Sree Pullugula, Jian-Xin Lin, Jangsuk Oh, Patrick Grandinetti, Mario Lecce, Leo Hesse, Emilia Kocks, Azucena Martín-Santos, Claudia Gebhard, William G Telford, Yun Ji, Nicholas P Restifo, Vincenzo Russo, Michael Rehli, Wolfgang Herr, Warren J Leonard, Luca Gattinoni
LIM-domain-only 4 (LMO4) enhances CD8 + T-cell stemness and tumor rejection by boosting IL-21-STAT3 signaling. Signal transduction and targeted therapy 9 (1) (2024)
Dragana Slavkovic-Lukic, Luca Gattinoni
Nanowires engineer naive T cells for immunotherapy. Nature nanotechnology 19 (8) (2024)
Caterina Scirgolea, Rosa Sottile, Marco De Luca, Alberto Susana, Silvia Carnevale, Simone Puccio, Valentina Ferrari, Veronica Lise, Giorgia Contarini, Alice Scarpa, Eloise Scamardella, Simona Feno, Chiara Camisaschi, Gabriele De Simone, Gianluca Basso, Desiree Giuliano, Emilia Maria Cristina Mazza, Luca Gattinoni, Rahul Roychoudhuri, Emanuele Voulaz, Diletta Di Mitri, Matteo Simonelli, Agnese Losurdo, Davide Pozzi, Carlson Tsui, Axel Kallies, Sara Timo, Giuseppe Martano, Elettra Barberis, Marcello Manfredi, Maria Rescigno, Sebastien Jaillon, Enrico Lugli
NaCl enhances CD8 + T cell effector functions in cancer immunotherapy. Nature immunology (2024)
Isabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi, Elena Ceccacci, Silvia Tiberti, Dorothee Haas, Jule Samson, Christoph Heuser, Carina B Nava Lauson, Marta Mangione, Elisa Preto, Alberto Bigogno, Eleonora Sala, Matteo Iannacone, Ciro Mercurio, Luca Gattinoni, Ignazio Caruana, Mirela Kuka, Luigi Nezi, Saverio Minucci, Teresa Manzo
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8 + T cell responsiveness. Nature communications 15 (1) (2024)
Isabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi, Elena Ceccacci, Silvia Tiberti, Dorothee Haas, Jule Samson, Christoph Heuser, Carina B Nava Lauson, Marta Mangione, Elisa Preto, Alberto Bigogno, Eleonora Sala, Matteo Iannacone, Ciro Mercurio, Luca Gattinoni, Ignazio Caruana, Mirela Kuka, Luigi Nezi, Saverio Minucci, Teresa Manzo
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8 + T cell responsiveness. Nature communications 15 (1) (2024)
Isabella Pallavicini, Teresa Maria Frasconi, Carlotta Catozzi, Elena Ceccacci, Silvia Tiberti, Dorothee Haas, Jule Samson, Christoph Heuser, Carina B Nava Lauson, Marta Mangione, Elisa Preto, Alberto Bigogno, Eleonora Sala, Matteo Iannacone, Ciro Mercurio, Luca Gattinoni, Ignazio Caruana, Mirela Kuka, Luigi Nezi, Saverio Minucci, Teresa Manzo
LSD1 inhibition improves efficacy of adoptive T cell therapy by enhancing CD8 + T cell responsiveness. Nature communications 15 (1) (2024)
Christoph Heuser, Luca Gattinoni
c-Myb redefines the hierarchy of stem-like T cells. Nature immunology 23 (10) (2022)
Jeremy G Baldwin, Luca Gattinoni
Cancer cells hijack T-cell mitochondria. Nature nanotechnology (2021)
Fei Mo, Zhiya Yu, Peng Li, Jangsuk Oh, Rosanne Spolski, Liang Zhao, Caleb R Glassman, Tori N Yamamoto, Yun Chen, Filip M Golebiowski, Dalton Hermans, Sonia Majri-Morrison, Lora K Picton, Wei Liao, Min Ren, Xiaoxuan Zhuang, Suman Mitra, Jian-Xin Lin, Luca Gattinoni, Jonathan D Powell, Nicholas P Restifo, K Christopher Garcia, Warren J Leonard
An engineered IL-2 partial agonist promotes CD8+ T cell stemness. Nature 597 (7877) (2021)
Chen Yao, Guohua Lou, Hong-Wei Sun, Ziang Zhu, Yi Sun, Zeyu Chen, Daniel Chauss, E Ashley Moseman, Jun Cheng, Marc A D'Antonio, Wangke Shi, Junwei Shi, Kohei Kometani, Tomohiro Kurosaki, E John Wherry, Behdad Afzali, Luca Gattinoni, Yuwen Zhu, Dorian B McGavern, John J O'Shea, Pamela L Schwartzberg, Tuoqi Wu
BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells. Nature immunology 22 (3) (2021)
Giovanni Galletti, Gabriele De Simone, Emilia M C Mazza, Simone Puccio, Claudia Mezzanotte, Timothy M Bi, Alexey N Davydov, Maria Metsger, Eloise Scamardella, Giorgia Alvisi, Federica De Paoli, Veronica Zanon, Alice Scarpa, Barbara Camisa, Federico Simone Colombo, Achille Anselmo, Clelia Peano, Sara Polletti, Domenico Mavilio, Luca Gattinoni, Shannon K Boi, Benjamin A Youngblood, Rhiannon E Jones, Duncan M Baird, Emma Gostick, Sian Llewellyn-Lacey, Kristin Ladell, David A Price, Dmitriy M Chudakov, Evan William Newell, Monica Casucci, Enrico Lugli
Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans. Nature immunology 21 (12) (2020)
Sanjivan Gautam, Jessica Fioravanti, Wei Zhu, John B Le Gall, Philip Brohawn, Neal E Lacey, Jinhui Hu, James D Hocker, Nga Voong Hawk, Veena Kapoor, William G Telford, Devikala Gurusamy, Zhiya Yu, Avinash Bhandoola, Hai-Hui Xue, Rahul Roychoudhuri, Brandon W Higgs, Nicholas P Restifo, Timothy P Bender, Yun Ji, Luca Gattinoni
The transcription factor c-Myb regulates CD8+ T cell stemness and antitumor immunity. Nature immunology 20 (3) (2019)
Gabriele De Simone, Emilia M C Mazza, Antonino Cassotta, Alexey N Davydov, Mirela Kuka, Veronica Zanon, Federica De Paoli, Eloise Scamardella, Maria Metsger, Alessandra Roberto, Karolina Pilipow, Federico Simone Colombo, Elena Tenedini, Enrico Tagliafico, Luca Gattinoni, Domenico Mavilio, Clelia Peano, David A Price, Satya P Singh, Joshua M Farber, Valentina Serra, Francesco Cucca, Francesco Ferrari, Valeria Orrù, Edoardo Fiorillo, Matteo Iannacone, Dmitriy M Chudakov, Federica Sallusto, Enrico Lugli
CXCR3 Identifies Human Naive CD8+ T Cells with Enhanced Effector Differentiation Potential. Journal of immunology (Baltimore, Md. : 1950) 203 (12) (2019)
Chen Yao, Hong-Wei Sun, Neal E Lacey, Yun Ji, E Ashley Moseman, Han-Yu Shih, Elisabeth F Heuston, Martha Kirby, Stacie Anderson, Jun Cheng, Omar Khan, Robin Handon, Julie Reilley, Jessica Fioravanti, Jinhui Hu, Selamawit Gossa, E John Wherry, Luca Gattinoni, Dorian B McGavern, John J O'Shea, Pamela L Schwartzberg, Tuoqi Wu
Single-cell RNA-seq reveals TOX as a key regulator of CD8+ T cell persistence in chronic infection. Nature immunology 20 (7) (2019)
Yun Ji, Jessica Fioravanti, Wei Zhu, Hongjun Wang, Tuoqi Wu, Jinhui Hu, Neal E Lacey, Sanjivan Gautam, John B Le Gall, Xia Yang, James D Hocker, Thelma M Escobar, Shan He, Stafania Dell'Orso, Nga V Hawk, Veena Kapoor, William G Telford, Luciano Di Croce, Stefan A Muljo, Yi Zhang, Vittorio Sartorelli, Luca Gattinoni
miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate. Nature communications 10 (1) (2019)
Charlotte M Mousset, Willemijn Hobo, Yun Ji, Hanny Fredrix, Valeria De Giorgi, Robert D Allison, Michel G D Kester, J H Frederik Falkenburg, Nicolaas P M Schaap, Joop H Jansen, Luca Gattinoni, Harry Dolstra, Anniek B van der Waart
Ex vivo AKT-inhibition facilitates generation of polyfunctional stem cell memory-like CD8+ T cells for adoptive immunotherapy. Oncoimmunology 7 (10) (2018)
Luca Gattinoni, Daniel E Speiser, Mathias Lichterfeld, Chiara Bonini
T memory stem cells in health and disease. Nature medicine 23 (1) (2017)
Shan He, Yongnian Liu, Lijun Meng, Hongxing Sun, Ying Wang, Yun Ji, Janaki Purushe, Pan Chen, Changhong Li, Jozef Madzo, Jean-Pierre Issa, Jonathan Soboloff, Ran Reshef, Bethany B Moore, Luca Gattinoni, Yi Zhang
Ezh2 phosphorylation state determines its capacity to maintain CD8+ T memory precursors for antitumor immunity. Nature communications 8 (1) (2017)
Luca Gattinoni
The dark side of T memory stem cells. Blood 125 (23) (2015)

Luca Gattinoni

Publication Activity (10 Years)

Top Topics

Top Venues